HERON THERAPEUTICS, INC. /DE/ Debt Instrument, Face Amount
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Debt Instrument, Face Amount of $4.67 million as of 2012-09-30, per its 10-Q filed 2012-11-05.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2012-11-05
- 2012-09-30: Debt Instrument, Face Amount $4.67M.
- 2012-06-30: Debt Instrument, Face Amount $4.62M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2012-09-30 | $4.67M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $4.62M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |